dc.contributor.author | Li, Ryan | |
dc.contributor.author | Rogier van Doorn, H | |
dc.contributor.author | Wertheim, Heiman FL | |
dc.contributor.author | Khue, Luong N | |
dc.contributor.author | Ha, Ngo TB | |
dc.contributor.author | Dat, Vu Q | |
dc.contributor.author | Hanh, Chu T | |
dc.contributor.author | Nga, Do TT | |
dc.contributor.author | Trang, Nghiem NM | |
dc.contributor.author | Behzad, Nadjm | |
dc.contributor.author | Cluzeau, Francoise | |
dc.contributor.author | Kinh, Nguyen V | |
dc.contributor.author | Trung, Nguyen V | |
dc.contributor.author | Huong, Nguyen TL | |
dc.contributor.author | Chau, Ngo Q | |
dc.contributor.author | Huong, La Q | |
dc.contributor.author | Thao, Le T | |
dc.contributor.author | Hong, Le TA | |
dc.contributor.author | Oanh, Tran TM | |
dc.contributor.author | Islam, Jasmin | |
dc.contributor.author | Roberts, C Michael | |
dc.contributor.author | Chalkidou, Kalipso | |
dc.date.accessioned | 2020-02-14T01:33:08Z | |
dc.date.available | 2020-02-14T01:33:08Z | |
dc.date.issued | 2016 | |
dc.identifier.issn | 2214-109X | |
dc.identifier.doi | 10.1016/S2214-109X(16)30267-4 | |
dc.identifier.uri | http://hdl.handle.net/10072/391456 | |
dc.description.abstract | Antimicrobial resistance is recognised as a serious global health threat requiring global action. However, much work remains to translate global strategies to combat antimicrobial resistance into national policy and action. In low-income and middle-income countries where vulnerable health-care systems require investment within constrained budgets, antimicrobial resistance strategies might not be prioritised, and indeed equitable versus restricted access to antibiotics present a conflicting challenge. 1 | |
dc.language | English | |
dc.language.iso | eng | |
dc.publisher | Elsevier | |
dc.relation.ispartofpagefrom | E789 | |
dc.relation.ispartofpageto | E789 | |
dc.relation.ispartofissue | 11 | |
dc.relation.ispartofjournal | Lancet Global Health | |
dc.relation.ispartofvolume | 4 | |
dc.subject.fieldofresearch | Microbiology | |
dc.subject.fieldofresearchcode | 3107 | |
dc.subject.keywords | Science & Technology | |
dc.subject.keywords | Life Sciences & Biomedicine | |
dc.subject.keywords | Public, Environmental & Occupational Health | |
dc.title | Combating antimicrobial resistance: quality standards for prescribing for respiratory infections in Vietnam | |
dc.type | Journal article | |
dc.type.description | C3 - Articles (Letter/ Note) | |
dcterms.bibliographicCitation | Li, R; Rogier van Doorn, H; Wertheim, HFL; Khue, LN; Ha, NTB; Dat, VQ; Hanh, CT; Nga, DTT; Trang, NNM; Behzad, N; Cluzeau, F; Kinh, NV; Trung, NV; Huong, NTL; Chau, NQ; Huong, LQ; Thao, LT; Hong, LTA; Oanh, TTM; Islam, J; Roberts, CM; Chalkidou, K, Combating antimicrobial resistance: quality standards for prescribing for respiratory infections in Vietnam, Lancet Global Health, 2016, 4 (11), pp. E789-E789 | |
dcterms.dateAccepted | 2016-08-25 | |
dcterms.license | https://creativecommons.org/licenses/by/4.0/ | |
dc.date.updated | 2020-02-14T01:30:29Z | |
dc.description.version | Version of Record (VoR) | |
gro.rights.copyright | © 2016 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the the terms of the Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. | |
gro.hasfulltext | Full Text | |
gro.griffith.author | Chalkidou, Kalipso | |